NNC 92-1687

CAS No. 22903-37-3

NNC 92-1687( —— )

Catalog No. M34348 CAS No. 22903-37-3

NNC 92-1687 is a selective glucagon receptor antagonist that can be used to study type 2 diabetes.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 603 Get Quote
5MG 922 Get Quote
10MG 1121 Get Quote
25MG 1454 Get Quote
50MG 1822 Get Quote
100MG 2250 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    NNC 92-1687
  • Note
    Research use only, not for human use.
  • Brief Description
    NNC 92-1687 is a selective glucagon receptor antagonist that can be used to study type 2 diabetes.
  • Description
    NNC 92-1687 is a selective glucagon receptor antagonist that can be used to study type 2 diabetes.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Glucagon Receptor
  • Recptor
    Glucagon Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    22903-37-3
  • Formula Weight
    300.33
  • Molecular Formula
    C15H12N2O3S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    S(CC(=O)C1=CC(O)=C(O)C=C1)C=2NC=3C(N2)=CC=CC3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • HAEGTFTSD

    HAEGTFTSD is the first N-terminal 1-9 residues of GLP-1 peptide.The GLP-1 (7-36) amide is a product of the preproglucagon gene, which is secreted from intestinal L-cells, in response to the ingestion of food.

  • GRA Ex-25

    A potent glucagon receptor inhibitor with IC50 of 56 and 55 nM for rat and human glucagon receptors.

  • Glucagon-like peptid...

    Glucagon-like peptide 1 (1-37), human is a highly potent agonist of the GLP-1 receptor.Pancreatic hormone synthesized by post-translational processing of proglucagon. Unlike truncated forms of GLP-1, it has no effect on food intake in rats and does not enhance pancreatic insulin secretion.